These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11002229)

  • 1. Quality of life changes during conformal radiation therapy for prostate carcinoma.
    Janda M; Gerstner N; Obermair A; Fuerst A; Wachter S; Dieckmann K; Pötter R
    Cancer; 2000 Sep; 89(6):1322-8. PubMed ID: 11002229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer.
    Geinitz H; Thamm R; Scholz C; Heinrich C; Prause N; Kerndl S; Keller M; Busch R; Molls M; Zimmermann FB
    Strahlenther Onkol; 2010 Jan; 186(1):46-52. PubMed ID: 20082188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG).
    Curran D; Fossa S; Aaronson N; Kiebert G; Keuppens F; Hall R
    Eur J Cancer; 1997 Oct; 33(11):1809-14. PubMed ID: 9470838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life among prostate cancer patients: a prospective longitudinal population-based study.
    Schaake W; de Groot M; Krijnen WP; Langendijk JA; van den Bergh AC
    Radiother Oncol; 2013 Aug; 108(2):299-305. PubMed ID: 23932157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in long-term survivors of oropharynx carcinoma.
    Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
    Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
    Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
    J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
    Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
    J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of men treated with brachytherapies for prostate cancer.
    Lev EL; Eller LS; Gejerman G; Lane P; Owen SV; White M; Nganga N
    Health Qual Life Outcomes; 2004 Jun; 2():28. PubMed ID: 15198803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?
    van den Bergh RC; de Blok W; van Muilekom E; Tillier C; Venderbos LD; van der Poel HG
    Scand J Urol; 2014 Aug; 48(4):367-73. PubMed ID: 24506062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
    Minniti G; Scaringi C; Baldoni A; Lanzetta G; De Sanctis V; Esposito V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):285-91. PubMed ID: 23642624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
    Lips IM; van Gils CH; van der Heide UA; Kruger AE; van Vulpen M
    BJU Int; 2009 Mar; 103(6):762-7. PubMed ID: 18990145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.
    Lehto US; Ojanen M; Väkevä A; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    Qual Life Res; 2019 Mar; 28(3):677-686. PubMed ID: 30511254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie R; Nicolay NH; Debus J; Rief H
    Anticancer Res; 2018 Aug; 38(8):4953-4960. PubMed ID: 30061275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.